Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?
The importance of understanding insulin action is emphasized by the increasing prevalence of insulin resistance in various populations and by the fact that it plays an important pathophysiological role in many common disorders, for example, diabetes, obesity, hypertension and dyslipidemia. The primary factors responsible for the development of insulin resistance are so far unknown, although both genetic and environmental factors are involved. The genetic defects responsible for the common forms of insulin resistance, for example, in type 2 diabetes, are largely unidentified. Some studies from our group as well as by other investigators suggest that cellular insulin resistance is reversible and that it may be secondary to factors in the in vivo environment. These may include insulin-antagonistic action of hormones like catecholamines, glucocorticoids, sex steroids and adipokines as well as dysregulation of autonomic nervous activity and they could contribute to the early development of insulin resistance. Some of these factors can directly impair glucose uptake capacity and this might be due to alterations in key proteins involved in insulin's intracellular signaling pathways. This article briefly summarizes proposed mechanisms behind cellular and whole-body insulin resistance. In particular, we question the role of intrinsic defects in insulin's target cells as primary mechanisms in the development of insulin resistance in type 2 diabetes and we suggest that metabolic and neurohormonal factors instead are the main culprits.
Department of Public Health and Clinical Medicine, Medicine, Umeå University Hospital, Umeå, Sweden. jonas.buren@medicin.umu.se
Jonas
J
Burén
Jan W
JW
Eriksson
D000273:Adipose Tissue / Q000502:physiology; D001341:Autonomic Nervous System / Q000503:physiopathology; D002490:Central Nervous System / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D006946:Hyperinsulinism / Q000503:physiopathology; D007030:Hypothalamo-Hypophyseal System / Q000166:cytology / Q000503:physiopathology; D007329:Insulin Antagonists / Q000378:metabolism; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology*; D020738:Leptin / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000166:cytology / Q000503:physiopathology; D011236:Prediabetic State / Q000503:physiopathology; D011972:Receptor, Insulin / Q000502:physiology*; D013312:Stress, Physiological / Q000503:physiopathology*
D007329:Insulin Antagonists; D020738:Leptin; D011972:Receptor, Insulin